ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
1-Year Return
95.37%
This Quarter Return
+37.46%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$213M
AUM Growth
+$20.4M
(+11%)
Cap. Flow
-$7.81M
Cap. Flow
% of AUM
-3.66%
Top 10 Holdings %
Top 10 Hldgs %
62.62%
Holding
43
New
2
Increased
13
Reduced
14
Closed
6
Top Buys
| 1 |
nLIGHT
LASR
|
+$11.8M |
| 2 |
Domo
DOMO
|
+$8.24M |
| 3 |
Allient
ALNT
|
+$7.26M |
| 4 |
Vishay Precision Group
VPG
|
+$4.49M |
| 5 |
Myomo
MYO
|
+$1.4M |
Top Sells
| 1 |
BK Technologies
BKTI
|
+$10.5M |
| 2 |
Intellicheck
IDN
|
+$7.78M |
| 3 |
Akebia Therapeutics
AKBA
|
+$5.62M |
| 4 |
Zevra Therapeutics
ZVRA
|
+$4.57M |
| 5 |
Delcath Systems
DCTH
|
+$3.32M |
Sector Composition
| 1 | Healthcare | 53.41% |
| 2 | Technology | 35.03% |
| 3 | Industrials | 11.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$519M
| $24.4M | 10.99% |
3,723,958
-244,990
| -6% | -$1.61M |
|
|
2
Domo
DOMO
$701M
| $18.7M | 8.43% |
1,341,518
+589,935
| +78% | +$8.24M |
|
3
scPharmaceuticals
SCPH
$302M
| $14.7M | 6.63% |
3,867,523
-228,844
| -6% | -$872K |
|
4
Arq
ARQ
$306M
| $14.3M | 6.41% |
2,654,486
-115,792
| -4% | -$622K |
|
|
5
Vishay Precision Group
VPG
$416M
| $11.9M | 5.35% |
423,484
+159,919
| +61% | +$4.49M |
|
|
6
nLIGHT
LASR
$1.43B
| $11.8M | 5.31% |
+600,103
| New | +$11.8M |
|
7
Lightpath Technologies
LPTH
$236M
| $11.2M | 5.05% |
3,642,377
-40,555
| -1% | -$125K |
|
8
Backblaze
BLZE
$534M
| $9.95M | 4.48% |
1,809,096
+96,775
| +6% | +$532K |
|
9
Verastem
VSTM
$598M
| $8.31M | 3.74% |
2,003,179
-334,575
| -14% | -$1.39M |
|
|
10
Zevra Therapeutics
ZVRA
$435M
| $8.1M | 3.64% |
918,893
-519,216
| -36% | -$4.57M |
|
|
11
Myomo
MYO
$31.9M
| $7.68M | 3.45% |
3,555,742
+649,053
| +22% | +$1.4M |
|
|
ELVA
12
Electrovaya
ELVA
$237M
| $7.35M | 3.31% |
2,155,836
-106,487
| -5% | -$363K |
|
|
13
Allient
ALNT
$779M
| $7.26M | 3.27% |
+200,000
| New | +$7.26M |
|
14
Elutia
ELUT
$54.3M
| $6.83M | 3.07% |
3,451,025
+69,610
| +2% | +$138K |
|
15
Coya Therapeutics
COYA
$101M
| $6.36M | 2.86% |
1,105,622
-78,158
| -7% | -$449K |
|
16
Heron Therapeutics
HRTX
$193M
| $6.23M | 2.8% |
3,009,257
+231,057
| +8% | +$478K |
|
|
THTX
17
Theratechnologies
THTX
$152M
| $4.91M | 2.21% |
2,082,491
-244,078
| -10% | -$576K |
|
18
AngioDynamics
ANGO
$433M
| $4.71M | 2.12% |
474,488
| – | – |
|
19
RenovoRx
RNXT
$46.9M
| $4.56M | 2.05% |
3,467,275
| – | – |
|
20
PolyPid
PYPD
$55.2M
| $4.22M | 1.9% |
1,194,108
+253,727
| +27% | +$896K |
|
21
Fennec Pharmaceuticals
FENC
$244M
| $3.75M | 1.69% |
452,400
+91,395
| +25% | +$759K |
|
|
GRCE
22
Grace Therapeutics, Inc. Common Stock
GRCE
$43.6M
| $3.35M | 1.51% |
1,128,497
-193,882
| -15% | -$576K |
|
23
Ideal Power
IPWR
$44.2M
| $3.03M | 1.36% |
668,623
-149,692
| -18% | -$678K |
|
24
AmpliTech
AMPG
$83.3M
| $1.92M | 0.86% |
905,453
| – | – |
|
25
KALA BIO
KALA
$131M
| $1.43M | 0.64% |
300,000
+103,650
| +53% | +$493K |
|